Artificial intelligence is rapidly reshaping dermatology with fifteen regulatory-approved devices worldwide, including three FDA-approved tools for skin cancer detection. Recent analyses confirm AI systems match or exceed clinician accuracy —especially in melanoma diagnosis—while broadening access via mobile platforms and diagnostic support for diverse skin conditions. Despite this promise, widespread implementation requires addressing data representation, privacy, and algorithmic fairness challenges. Future directions emphasize robust validation, diverse datasets, and integration into clinical workflows to optimize patient outcomes and support dermatologists across care settings.
To read more.... Click Here ##Reference## Nahm WJ, Sohail N, Burshtein J, Goldust M, Tsoukas M. Artificial Intelligence in Dermatology: A Comprehensive Review of Approved Applications, Clinical Implementation,…
